Skip to content
Screener

DaVita DVA Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$10M0.0%
ARD
Ardent Health PartnersARDT
$50M0.0%
ICU Medical logo
ICU MedicalICUI
$500K0.0%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
InfuSystem Holdings logo
InfuSystem HoldingsINFU
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$3.4B+6.0%
Operating income$481.9M+9.8%
Net income$197.5M+21.2%
EPS (diluted)$2.87+43.5%

Balance sheet

See full
Cash & equivalents$726.4M+38.5%
Total debt$13.3B+6.7%
Total equity-$755.5M-183%
Total assets$17.5B+2.2%

Cash flow

See full
Operating cash flow$320.8M+78.2%
CapEx$102.0M-28.8%
Free cash flow$218.8M+495%

Valuation

See full
Market cap$11.72B+27.0%
Enterprise value$24.33B+13.5%
P/E15×+4.0×
P/S0.9×+0.1×

Profitability

See full
Operating margin15.1%-0.7pp
Net margin5.6%-1.0pp
FCF margin10.8%-2.8pp

Returns & leverage

See full
Return on equity159.1%+80.9pp
Debt / equity103.6×+92.8×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by DaVita in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: DaVita’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 5:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000927066-26-000062
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies
Noncontrolling interests subject to put provisions1,524,5051,532,166
Equity:
Preferred stock ($0.001 par value, 5,000 shares authorized; none issued)
Common stock ($0.001 par value, 450,000 shares authorized; 69,190 shares issued and 66,185 outstanding at March 31, 2026, respectively, and 68,549 shares issued and outstanding at December 31, 2025)6969
Additional paid-in capital
Accumulated deficit(179,242)(328,428)
Treasury stock (3,005 and zero shares, respectively)(489,364)(199,940)

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is DaVita's preferred stock, shares authorized?
DaVita (DVA) reported preferred stock, shares authorized of $5M in Q1 2026.
How has DaVita's preferred stock, shares authorized changed year-over-year?
DaVita's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for DaVita's preferred stock, shares authorized?
Over 5 years (2020 to 2025), DaVita's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.

Ask your AI about DaVita's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude